Antibiotic Drug Push By Administration Could Include BARDA Incubator

As NIH workshop discusses novel approaches to combatting antibiotic resistance from monoclonal antibodies to synthetic stool transplants and antimicrobial peptides, plans are underway to expand BARDA’s focus beyond biodefense.

The Obama Administration’s strategy for combating antibiotic resistance includes expanding the mission of the Biomedical Advanced Research and Development Authority (BARDA) beyond supporting biodefense products.

The shift is part of an executive order directing federal departments and agencies to implement the administration’s National Strategy on...